U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H15N5O3
Molecular Weight 241.2471
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SAPROPTERIN

SMILES

[H][C@@]1(CNC2=C(N1)C(=O)N=C(N)N2)[C@@H](O)[C@H](C)O

InChI

InChIKey=FNKQXYHWGSIFBK-RPDRRWSUSA-N
InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,4+,6-/m0/s1

HIDE SMILES / InChI

Molecular Formula C9H15N5O3
Molecular Weight 241.2471
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 15:49:48 UTC 2023
Edited
by admin
on Sat Dec 16 15:49:48 UTC 2023
Record UNII
EGX657432I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SAPROPTERIN
INN   MI   VANDF   WHO-DD  
INN  
Official Name English
R-THBP
Common Name English
SAPROPTERIN [MI]
Common Name English
(6R)-2-AMINO-6-((1R,2S)-1,2-DIHYDROXYPROPYL)-5,6,7,8-TETRAHYDROPTERIDIN-4(1H)-ONE
Systematic Name English
BH4
Common Name English
SAPROPTERIN [VANDF]
Common Name English
6R-BH4
Common Name English
DAPROPTERIN
Common Name English
Sapropterin [WHO-DD]
Common Name English
TETRAHYDROBIOPTERIN
Common Name English
4(1H)-PTERIDINONE, (6R)-2-AMINO-6-((1R,2S)-1,2-DIHYDROXYPROPYL)-5,6,7,8-TETRAHYDRO-
Systematic Name English
(6R)-L-ERYTHRO-TETRAHYDROBIOPTERIN
Common Name English
sapropterin [INN]
Common Name English
(6R)-2-AMINO-6-((1R,2S)-1,2-DIHYDROXYPROPYL)-5,6,7,8-TETRAHYDRO-4(1H)-PTERIDINONE
Systematic Name English
Classification Tree Code System Code
LOINC 59247-7
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
LOINC 33877-2
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
WHO-ATC A16AX07
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
NCI_THESAURUS C275
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
WHO-VATC QA16AX07
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
NDF-RT N0000190483
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
FDA ORPHAN DRUG 181503
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
EU-Orphan Drug EU/3/05/308
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
NCI_THESAURUS C1916
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
Code System Code Type Description
CAS
62989-33-7
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
LACTMED
Sapropterin
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
ChEMBL
CHEMBL1201774
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
CHEBI
59560
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
NDF-RT
N0000190482
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY Phenylalanine Hydroxylase Activators [MoA]
DRUG BANK
DB00360
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
SMS_ID
100000084074
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
CAS
17528-72-2
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
NON-SPECIFIC STEREOCHEMISTRY
IUPHAR
5276
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
DAILYMED
EGX657432I
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
INN
6553
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
WIKIPEDIA
TETRAHYDROBIOPTERIN
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
NCI_THESAURUS
C78087
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
RXCUI
753340
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY RxNorm
NDF-RT
N0000190113
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY Breast Cancer Resistance Protein Inhibitors [MoA]
EPA CompTox
DTXSID1041138
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
PUBCHEM
135398654
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
EVMPD
SUB10445MIG
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
CAS
27070-47-9
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
ALTERNATIVE
CHEBI
15372
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
MERCK INDEX
m9775
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY Merck Index
NDF-RT
N0000185503
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY P-Glycoprotein Inhibitors [MoA]
DRUG CENTRAL
2612
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
FDA UNII
EGX657432I
Created by admin on Sat Dec 16 15:49:49 UTC 2023 , Edited by admin on Sat Dec 16 15:49:49 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life ENZYMATIC ORAL ADMINISTRATION

Tmax ENZYMATIC ORAL ADMINISTRATION